Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 3, 2018Thoracic CancerOpen Access

Outcomes of bevacizumab combined with chemotherapy in lung adenocarcinoma‐induced malignant pleural effusion

View Full Paper
Ask AI
Bookmark
Share

Authors

HTHong TaoQMQiyi MengMLMingzhi Li

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tao et al. (2018) studied this question.

synapsesocial.com/papers/69faa282292a850ef29e265bhttps://doi.org/10.1111/1759-7714.12582
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Tunneled Pleural Catheter for the Treatment of Malignant Pleural Effusion: A Systematic Review and Meta-analysis2015 · 17 citations
  2. 2The angiogenetic pathway in malignant pleural effusions: Pathogenetic and therapeutic implications2009 · 26 citations
  3. 3Response to bevacizumab combination chemotherapy of malignant pleural effusions associated with non-squamous non-small-cell lung cancer2014 · 37 citations
  4. 4Intrapleural therapy2011 · 15 citations